TRimetazidine as an Agent to affeCt clopidogrEl Response: The TRACER Study

INTRODUCTION: This prospective study aimed to determine whether trimetazidine (TMZ) alters the pharmacodynamic (PD) effects of clopidogrel. METHODS: Patients with stable coronary artery disease (SCAD) (n = 24) who were actively treated with dual antiplatelet therapy (DAPT) of aspirin 81 mg daily and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cardiol Ther
Autors principals: Seecheran, Naveen, Seebalack, Victoria, Seecheran, Rajeev, Maharaj, Aarti, Boodhai, Brent, Seecheran, Valmiki, Persad, Sangeeta, Motilal, Shastri, Tello-Montoliu, Antonio, Schneider, David
Format: Artigo
Idioma:Inglês
Publicat: Springer Healthcare 2019
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6828882/
https://ncbi.nlm.nih.gov/pubmed/31292901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40119-019-0139-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars